128 related articles for article (PubMed ID: 37981171)
1. Role of psa levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy.
Santucci D; Vertulli D; Esperto F; Eolo Trodella L; Ramella S; Papalia R; Scarpa RM; de Felice C; Francesco Grasso R; Beomonte Zobel B; Faiella E
Actas Urol Esp (Engl Ed); 2024 Mar; 48(2):140-149. PubMed ID: 37981171
[TBL] [Abstract][Full Text] [Related]
2. The role of multiparametric mri in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy.
Faiella E; Santucci D; Vertulli D; Esperto F; Messina L; Castiello G; Papalia R; Flammia G; Scarpa RM; Fiore M; Trodella LE; Ramella S; Grasso RF; Beomonte Zobel B
Actas Urol Esp (Engl Ed); 2022 Sep; 46(7):397-406. PubMed ID: 35778338
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
5. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
Venkatesan AM; Mudairu-Dawodu E; Duran C; Stafford RJ; Yan Y; Wei W; Kundra V
Cancer Imaging; 2021 Jan; 21(1):3. PubMed ID: 33407861
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
Mazzone E; Gandaglia G; Ploussard G; Marra G; Valerio M; Campi R; Mari A; Minervini A; Serni S; Moschini M; Marquis A; Beauval JB; van den Bergh R; Rahota RG; Soeterik T; Roumiguiè M; Afferi L; Zhuang J; Guo H; Mattei A; Gontero P; Cucchiara V; Stabile A; Fossati N; Montorsi F; Briganti A
Eur Urol; 2022 Feb; 81(2):193-203. PubMed ID: 34399996
[TBL] [Abstract][Full Text] [Related]
7. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy.
Ho R; Siddiqui MM; George AK; Frye T; Kilchevsky A; Fascelli M; Shakir NA; Chelluri R; Abboud SF; Walton-Diaz A; Sankineni S; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
PLoS One; 2016; 11(6):e0157313. PubMed ID: 27336392
[TBL] [Abstract][Full Text] [Related]
9. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
10. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
12. Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
Kowa JY; Soneji N; Sohaib SA; Mayer E; Hazell S; Butterfield N; Shur J; Ap Dafydd D
Br J Radiol; 2021 Apr; 94(1120):20201423. PubMed ID: 33586998
[TBL] [Abstract][Full Text] [Related]
13. Influential factors in the response to salvage radiotherapy after radical prostatectomy.
Algarra R; Tienza A; Hevia M; Zudaire J; Rosell D; Robles JE; Pascual I
Actas Urol Esp; 2014 Dec; 38(10):662-8. PubMed ID: 24796523
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer.
Breen WG; Stish BJ; Harmsen WS; Froemming AT; Mynderse LA; Choo CR; Davis BJ; Pisansky TM
Radiother Oncol; 2021 Aug; 161():9-15. PubMed ID: 34023327
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy.
Coppola A; Platania G; Ticca C; De Mattia C; Bortolato B; Palazzi MF; Vanzulli A
Radiol Med; 2020 Jul; 125(7):683-690. PubMed ID: 32078119
[TBL] [Abstract][Full Text] [Related]
16. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
17. Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4.
Kim H; Kim JK; Hong SK; Jeong CW; Ku JH; Kwak C
World J Urol; 2021 Jun; 39(6):1825-1830. PubMed ID: 32869150
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.
Ucar T; Gunduz N; Demirci E; Culpan M; Gunel H; Kir G; Atis RG; Yildirim A
Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values.
Franco PN; Frade-Santos S; García-Baizán A; Paredes-Velázquez L; Aymerich M; Sironi S; Otero-García MM
Eur Radiol; 2024 Mar; 34(3):1790-1803. PubMed ID: 37646815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]